Sweden · Delayed Price · Currency is SEK CirChem AB Statistics
Total Valuation
CirChem AB has a market cap or net worth of SEK 28.06 million. The enterprise value is 34.60 million.
| Market Cap | 28.06M |
| Enterprise Value | 34.60M |
Important Dates
The next estimated earnings date is Thursday, August 6, 2026.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CirChem AB has 40.21 million shares outstanding. The number of shares has increased by 22.79% in one year.
| Current Share Class | 40.21M |
| Shares Outstanding | 40.21M |
| Shares Change (YoY) | +22.79% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 1.64% |
| Owned by Institutions (%) | n/a |
| Float | 39.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.34 |
| PB Ratio | 0.71 |
| P/TBV Ratio | 0.71 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.89 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.94, with a Debt / Equity ratio of 0.34.
| Current Ratio | 0.94 |
| Quick Ratio | 0.82 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.59 |
| Interest Coverage | -14.37 |
Financial Efficiency
Return on equity (ROE) is -37.02% and return on invested capital (ROIC) is -17.82%.
| Return on Equity (ROE) | -37.02% |
| Return on Assets (ROA) | -14.78% |
| Return on Invested Capital (ROIC) | -17.82% |
| Return on Capital Employed (ROCE) | -27.46% |
| Weighted Average Cost of Capital (WACC) | 13.51% |
| Revenue Per Employee | 998,750 |
| Profits Per Employee | -1.29M |
| Employee Count | 12 |
| Asset Turnover | 0.20 |
| Inventory Turnover | 29.13 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -70.17% in the last 52 weeks. The beta is 2.33, so CirChem AB's price volatility has been higher than the market average.
| Beta (5Y) | 2.33 |
| 52-Week Price Change | -70.17% |
| 50-Day Moving Average | 0.91 |
| 200-Day Moving Average | 1.16 |
| Relative Strength Index (RSI) | 39.57 |
| Average Volume (20 Days) | 93,820 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CirChem AB had revenue of SEK 11.99 million and -15.50 million in losses. Loss per share was -0.41.
| Revenue | 11.99M |
| Gross Profit | -5.61M |
| Operating Income | -14.50M |
| Pretax Income | -15.50M |
| Net Income | -15.50M |
| EBITDA | -13.38M |
| EBIT | -14.50M |
| Loss Per Share | -0.41 |
Balance Sheet
The company has 6.77 million in cash and 13.31 million in debt, with a net cash position of -6.54 million or -0.16 per share.
| Cash & Cash Equivalents | 6.77M |
| Total Debt | 13.31M |
| Net Cash | -6.54M |
| Net Cash Per Share | -0.16 |
| Equity (Book Value) | 39.49M |
| Book Value Per Share | 0.98 |
| Working Capital | -652,000 |
Cash Flow
In the last 12 months, operating cash flow was -15.54 million and capital expenditures -7.15 million, giving a free cash flow of -22.68 million.
| Operating Cash Flow | -15.54M |
| Capital Expenditures | -7.15M |
| Depreciation & Amortization | 1.12M |
| Net Borrowing | 10.41M |
| Free Cash Flow | -22.68M |
| FCF Per Share | -0.56 |
Margins
Gross margin is -46.79%, with operating and profit margins of -120.98% and -129.35%.
| Gross Margin | -46.79% |
| Operating Margin | -120.98% |
| Pretax Margin | -129.35% |
| Profit Margin | -129.35% |
| EBITDA Margin | -111.64% |
| EBIT Margin | -120.98% |
| FCF Margin | n/a |
Dividends & Yields
CirChem AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -22.79% |
| Shareholder Yield | -22.79% |
| Earnings Yield | -55.24% |
| FCF Yield | -80.83% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CirChem AB has an Altman Z-Score of 0.52. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.52 |
| Piotroski F-Score | n/a |